Big Pharma 2013. Will we see real commitment to change?

2013 needs to be a year of major, actionable change in pharma.

I am also writing about creativity squashers in Big Pharma in my mini-series “Are you there, Pharma? It’s me, Liz.”


The familiar rituals of festive celebration can be a comfort to many, and prudent hosts remember that such occasions are not a time for innovation. Family, friends and guests are more likely to enjoy the shared pleasures of participating in a ritual’s traditions than they are to be craving diversion from its norms.

However, beyond a certain point the appeal of the familiar can quickly wane. Not only can we have a surfeit of convention; we can also become thoroughly nauseated by it.

Reviewing some of the customary ‘New Year’s predictions for pharma’ posts on returning to my desk this week, I felt more than a little queasy (this post by Digitally Sick colleague Alex Butler being a notable exception).

Unlike the celebrations that precede it, the New Year is a time to take a fresh look at the problems that confront us, not merely to resume…

View original post 399 more words

Leave a reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s